Clinical Trials in Minneapolis

Showing 4981-5000 of 11,007 trials

Validation of a Digital Visual Analogue Scale for Appetite Measurement

NCT05287516

The objective of the study is to validate a newly developed digital visual analog scales with a mobile app for measuring human appetite and compare it with a traditional paper-based visual analog scales for appetite measurement.

Healthy

General Mills130 participantsStarted Apr 2022

Minneapolis, Minnesota, United States

COMPLETEDNA< 1 mile

Active Powered Prosthesis (APEX) for Spinal Cord Injury

NCT03696927

The Active Powered Prosthesis (APEX) (AbiliTech Medical Inc., Minneapolis, MN) is a proof-of-concept shoulder-elbow-wrist device intended to provide non-invasive active powered robotic assistive movement to upper extremities. The objective of this study is to perform focus groups with users and clinicians to evaluate a proof of concept active powered assistance device.

Spinal Cord Injuries

AbiliTech Medical Inc.4 participantsStarted Aug 2018

Minneapolis, Minnesota, United States

TERMINATEDPhase 1/2< 1 mile

GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies

NCT03214666

This is a multi-center Phase I/II clinical trial of GTB-3550 (CD16/IL-15/CD33) tri-specific killer cell engager (TriKE®) for the treatment of CD33-expressing high risk myelodysplastic syndromes, refractory/relapsed acute myeloid leukemia or advanced systemic mastocytosis. The hypothesis is that GTB-3550 TriKE® will induce natural killer cell function by targeting malignant cells as well as CD33+ myeloid derived suppressor cells (MDSC) which contribute to tumor induced immunosuppression. Because CD16 is the most potent activating receptor on natural killer (NK) cells, this single agent may induce a targeted anti-CD33+ tumor response.

High-risk Myelodysplastic SyndromesAcute Myelogenous LeukemiaSystemic Mastocytosis+1 more

GT Biopharma, Inc.12 participantsStarted Jan 2020

Minneapolis, Minnesota, United States • Madison, Wisconsin, United States

Validation of a Digital Visual Analogue Scale for Appetite Measurement

Active Powered Prosthesis (APEX) for Spinal Cord Injury

GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies

Find Trials by Condition in Minneapolis

e-Cigarette - DNA Adducts

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma

LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients

TruGraf® Long-term Clinical Outcomes Study

Predictive Assay for Decision Making in Adjuvant Therapy

A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder

Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain

A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma

A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis

Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients

Sotrovimab Expanded Access Treatment Protocol (COVID-19)

Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury

A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE)

Vascular Inflammation in Psoriasis - Apremilast